EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sree Rayalaseema Hi-Strength Hypo EBITDA Margin % Related Terms
Sree Rayalaseema Hi-Strength Hypo EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Sree Rayalaseema Hi-Strength Hypo's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sree Rayalaseema Hi-Strength Hypo EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sree Rayalaseema Hi-Strength Hypo's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sree Rayalaseema Hi-Strength Hypo's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sree Rayalaseema Hi-Strength Hypo (BOM:532842) has a EBITDA Margin % of 15.74% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sree Rayalaseema Hi-Strength Hypo and its competitors. This is 15% above median its historical median of 13.72. Over the past decade, Sree Rayalaseema Hi-Strength Hypo's EBITDA Margin % has ranged from 11.29 to 20.14. According to the industry distribution chart, Sree Rayalaseema Hi-Strength Hypo ranks #310 out of 1579 companies in the Chemicals industry, placing it in the top 19.6%.
Is Sree Rayalaseema Hi-Strength Hypo's EBITDA Margin % too high?
Sree Rayalaseema Hi-Strength Hypo's current EBITDA Margin % of 15.74% is 15% above median its 10-year median of 13.72. Over the past 10 years, this metric has ranged from a low of 11.29 to a high of 20.14. The Chemicals industry median EBITDA Margin % is 9.63. Sree Rayalaseema Hi-Strength Hypo's value of 15.74% is 63.4% above this industry median. Based on the distribution chart, Sree Rayalaseema Hi-Strength Hypo ranks #310 out of 1579 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Sree Rayalaseema Hi-Strength Hypo has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sree Rayalaseema Hi-Strength Hypo's EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Sree Rayalaseema Hi-Strength Hypo ranks #310 out of 1579 companies for EBITDA Margin %. This places Sree Rayalaseema Hi-Strength Hypo in the top 20% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.63. Sree Rayalaseema Hi-Strength Hypo's value of 15.74% is 63.4% above this benchmark. Historically, Sree Rayalaseema Hi-Strength Hypo's own EBITDA Margin % has ranged from 11.29 to 20.14 over the past decade. While the company's 10-year median is 13.72 vs. the industry median of 9.63, Sree Rayalaseema Hi-Strength Hypo has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sree Rayalaseema Hi-Strength Hypo's current EBITDA Margin % of 15.74% is 63.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sree Rayalaseema Hi-Strength Hypo and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sree Rayalaseema Hi-Strength Hypo's current EBITDA Margin % is 15.74%, which is 15% above median its own 10-year median of 13.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sree Rayalaseema Hi-Strength Hypo stock overvalued right now?
Based on GuruFocus' analysis, Sree Rayalaseema Hi-Strength Hypo (BOM:532842) is currently considered Fairly Valued. The stock's GF Value™ is ₹469.14, compared to a current price of ₹487.25 — trading 3.9% above its estimated fair value. The current EBITDA Margin % is 15.74%, which is 15% above median its 10-year median of 13.72 and 63.4% above the Chemicals industry median of 9.63. Sree Rayalaseema Hi-Strength Hypo's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sree Rayalaseema Hi-Strength Hypo (BOM:532842), the current EBITDA Margin % is 15.74% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sree Rayalaseema Hi-Strength Hypo (BOM:532842) Overvalued in 2026?
Based on GuruFocus' analysis, Sree Rayalaseema Hi-Strength Hypo stock appears to be overvalued.
The current stock price of ₹487.25 is trading 3.9% above its estimated GF Value™ of ₹469.14.
GuruFocus considers Sree Rayalaseema Hi-Strength Hypo to be Fairly Valued.
Key valuation signals for BOM:532842:
EBITDA Margin %: 15.74% (15% above median its 10-year median of 13.72)
GF Value™: ₹469.14 vs. price of ₹487.25 (3.9% above fair value)
Industry Position: 63.4% above the Chemicals median (#310 of 1579)
No single metric tells the full story. See the BOM:532842 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sree Rayalaseema Hi-Strength Hypo Business Description
Sree Rayalaseema Hi-Strength Hypo Ltd is an India-based company engaged in manufacturing inorganic chemicals and generating power through wind and thermal. The company has three reportable segments: Chemical manufacturing and Power Generation, and Trading in Coal, of which Chemical manufacturing segment. The company's products include Sulphuric acid, Chlorosulphonic acid, Chloramine, oleum, Hydrochloric acid, Monochloro acetic acid, Sodium dichloro isocyanurate, Hydrogen gas, Aluminium sulfate, Stable bleaching powder, Sodium hydride, Sodium methoxide powder, Sodium methoxide solution, and Water treatment chemicals.
69GF Score
Get the complete analysis for BOM:532842
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:532842 has been successfully added to your 
